EcoDrugPlus

G Protein-Coupled Receptor 119

Ensembl ID : ENSOSIG00000017749
Gene Symbol: GPR119
1 Cross references
174 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSOSIG00000000624
Gene Symbol: HCK
1 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSOSIG00000000378
Gene Symbol: ITK
1 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSOSIG00000021287
Gene Symbol: IMPDH1B
1 Cross references
256 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSOSIG00000019664
Gene Symbol: IMPDH1B
1 Cross references
256 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSOSIG00000009600
Gene Symbol: IMPDH2
1 Cross references
200 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSOSIG00000019729
Gene Symbol: JAK1
1 Cross references
212 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSOSIG00000014772
Gene Symbol: JAK2
1 Cross references
194 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSOSIG00000017472
Gene Symbol: JAK2A
1 Cross references
199 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSOSIG00000021456
Gene Symbol: KITB
1 Cross references
200 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSOSIG00000001234
Gene Symbol: MAPKAPK2
1 Cross references
187 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSOSIG00000022093
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).